Building muscle, browning fat and preventing obesity by inhibiting myostatin

Diabetologia

Volumn 55, Issue 1, 2012, Pages 13-17

  LeBrasseur, N K ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

ActRIIB; Adipogenesis; Brown fat; Diabetes; Fatty acid oxidation; Myostatin; Skeletal muscle

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MYOSTATIN; RECOMBINANT PROTEIN; SOLUBLE DECOY ACTIVIN TYPE IIB RECEPTOR; UNCLASSIFIED DRUG;

BODY FAT DISTRIBUTION; BODY WEIGHT; DRUG MECHANISM; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FOOD INTAKE; GENE EXPRESSION; HUMAN; INTRACELLULAR SIGNALING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; DIET, HIGH-FAT; FATTY ACIDS; MALE; MYOSTATIN; OBESITY;

EID: 84856714403     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2361-8     Document Type: Review

References (27)

1. Finucane MM, Stevens GA, Cowan MJ et al (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 91 million participants. Lancet 377:557-567
2. Shaw K, Gennat H, O'Rourke P, Del Mar C (2006) Exercise for overweight or obesity. Cochrane Database Syst Rev, Issue 4. Art. no.:CD003817. doi:10.1002/14651858.CD003817.pub3 (Pubitemid 46841204)
3. Zhang C, McFarlane C, Lokireddy S et al (2011) Inhibition of myostatin protects against diet-induced obesity through enhancing fatty acid oxidation and promoting brown adipose phenotype. Diabetologia. doi:10.1007/s00125-011-2304-4
4. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83-90 (Pubitemid 27202654)
5. McPherron AC, Lee S-J (1997) Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci 94:12457-12461 (Pubitemid 27492550)
6. Schuelke M, Wagner KR, Stolz LE et al (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350:2682-2688 (Pubitemid 38788003)
7. LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA (2009) Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci 64:940-948
8. Zhou X, Wang JL, Lu J et al (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. cell 142:531-543
9. Bogdanovich S, Krag TOB, Barton ER et al (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418-421 (Pubitemid 35415652)
10. Zimmers TA, Davies MV, Koniaris LG et al (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296:1486-1488 (Pubitemid 34553097)
11. Wagner KR, Liu X, Chang X, Allen RE (2005) Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A 102:2519-2524 (Pubitemid 40279409)
12. Allen DL, Hittel DS, McPherron AC (2011) Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc 43:1828-1835
13. LeBrasseur NK, Walsh K, Arany Z (2011) Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am J Physiol Endocrinol Metab 300:E3-E10
14. Cypess AM, Lehman S, Williams G et al (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509-1517
15. Virtanen KA, Lidell ME, Orava J et al (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360:1518-1525
16. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM et al (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360:1500-1508
17. Akpan I, Goncalves MD, Dhir R et al (2009) The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) 33:1265-1273
18. Zhang C, McFarlane C, Lokireddy S et al (2011) Myostatindeficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 54:1491-1501
19. Ruderman NB, Saha AK, Kraegen EW (2003) Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144:5166-5171 (Pubitemid 37476042)
20. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC (2009) Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4:e4937
21. Wilkes JJ, Lloyd DJ, Gekakis N (2009) Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 58:1133-1143
22. Bernardo BL, Wachtmann TS, Cosgrove PG et al (2010) Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulinresistant mice. PLoS One 5:e11307
23. Tu P, Bhasin S, Hruz PW et al (2009) Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes 58:1739-1748
24. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA (2009) Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58:30-38
25. Milan G, Dalla Nora E, Pilon C et al (2004) Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab 89:2724-2727 (Pubitemid 38766356)
26. Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP (2006) GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics 27:114-121 (Pubitemid 46702026)
27. Palsgaard J, Brons C, Friedrichsen M et al (2009) Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS One 4:e6575